Study Supports Pre-Surgery Use of GLP-1 RAs for Weight Reduction

Study supports pre-surgery use of GLP-1 RAs for weight reduction

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of surgical complications linked to their obesity, a new study reveals.

Obese surgical patients can safely use GLP-1 therapy to reduce risk of complications, study concludes

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of surgical complications linked to their obesity, a new study reveals.

Surgical patients can safely use GLP-1s to lose weight and reduce risk of complications

Patients waiting for operations could safely use glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to lose excess weight and reduce their risk of surgical complications linked to their obesity, a study by researchers from the University of Birmingham has revealed.The study highlights GLP-1 RAs are a promising medication given before surgery that helps control blood sugar and supports weight loss, potentially improving surgical outcomes and r…

Study Finds GLP-1 Receptor Agonists Safe for Overweight Patients to Reduce Surgical Risks

A recent study has found that overweight patients await […] The post Study Finds GLP-1 Receptor Agonists Safe for Overweight Patients to Reduce Surgical Risks first appeared on GeneOnline News. The post Study Finds GLP-1 Receptor Agonists Safe for Overweight Patients to Reduce Surgical Risks appeared first on GeneOnline News.